Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.1K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.4K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

379
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

666
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
666

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trustworthy Artificial Intelligence in Health Requires Public Health Leadership.

American journal of public health·2026
Same author

Navigating an unpredictable supply: lived experiences of xylazine exposure among people who use drugs.

Harm reduction journal·2026
Same author

The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities Study.

Addiction (Abingdon, England)·2026
Same author

Gabapentin to achieve HIV viral load suppression in people with risky drinking in Mbarara, Uganda: study protocol for a randomized, double-blinded, placebo-controlled trial (GRAIL).

Trials·2026
Same author

Treatments for Opioid Overdose-Reply.

JAMA·2026
Same author

COVID-19 pandemic-related stress and substance use behaviors among people with HIV - a mixed method analysis.

PloS one·2026

Related Experiment Video

Updated: Apr 27, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

965

Postpartum changes in methadone maintenance dose.

Christine A Pace1, Leah B Kaminetzky2, Michael Winter3

  • 1Clinical Addictions Research and Education (CARE) Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine/Boston Medical Center, 801 Massachusetts Avenue, Boston, MA 02118.

Journal of Substance Abuse Treatment
|June 24, 2014
PubMed
Summary
This summary is machine-generated.

Postpartum methadone maintenance doses showed minimal changes. While oversedation events remained low, a slight increase in postpartum women and those on benzodiazepines warrants further study on optimal dosing strategies.

Keywords:
Methadone maintenance treatmentOpioid dependencePostpartumPregnancy

More Related Videos

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

17.6K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

90.5K

Related Experiment Videos

Last Updated: Apr 27, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

965
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

17.6K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

90.5K

Area of Science:

  • Obstetrics and Gynecology
  • Addiction Medicine
  • Pharmacology

Background:

  • Optimal postpartum methadone maintenance dosing strategies remain unclear.
  • Methadone maintenance treatment (MMT) is crucial for pregnant women with opioid use disorder.
  • Postpartum period presents unique physiological changes affecting medication metabolism.

Purpose of the Study:

  • To examine methadone dosing and oversedation events in postpartum women.
  • To compare postpartum oversedation incidence with that during pregnancy.
  • To investigate the impact of benzodiazepine co-prescription on oversedation.

Main Methods:

  • Prospective study of 101 methadone-maintained pregnant women.
  • Dose assessment at 2, 6, and 12 weeks postpartum.
  • Comparison of oversedation event incidence during pregnancy and postpartum.

Main Results:

  • Average methadone dose at delivery was 83.3mg; mean decrease by 12 weeks postpartum was 3.7mg.
  • Oversedation incidence per 10,000 days was 2.8 (pregnant) vs. 5.6 (postpartum).
  • Adjusted incidence rate ratio for postpartum oversedation was 1.74 (CI 0.56, 5.30), not statistically significant.

Conclusions:

  • Postpartum methadone dose adjustments were small in a clinic relying on clinical assessment.
  • A non-significant increase in oversedation events postpartum, especially with benzodiazepines, needs further investigation.
  • More frequent clinical assessments up to 12 weeks postpartum may be beneficial, though data for routine dose reduction is insufficient.